TD ASSET MANAGEMENT INC

Holdings History for Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (PRLD)

Symbol: PRLD on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$465,891	160,652	0		$2.90	Q4 2025
30 Sep 2025	0%	0%	$231,339	160,652	0		$1.44	Q3 2025
30 Jun 2025	0%	0%	$130,032	160,652	0		$0.81	Q2 2025
31 Mar 2025	0%	0%	$123,381	160,652	0		$0.77	Q1 2025
31 Dec 2024	0%	0%	$204,831	160,652	0		$1.27	Q4 2024
30 Sep 2024	0%	0%	$340,582	160,652	0		$2.12	Q3 2024
30 Jun 2024	0%	0%	$612,084	160,652	0		$3.81	Q2 2024
31 Mar 2024	0%	0%	$761,490	160,652	0		$4.74	Q1 2024
31 Dec 2023	0%	0%	$685,984	160,652	0		$4.27	Q4 2023
30 Sep 2023	0%	+0%	$496,415	160,652	+80,326	+100%	$3.09	Q3 2023
30 Jun 2023	0%	+0%	$361,467	80,326	+51,886	+182%	$4.50	Q2 2023
31 Mar 2023	0%	0%	$162,108	28,440	0		$5.70	Q1 2023
31 Dec 2022	0%	0%	$171,778	28,440	0		$6.04	Q4 2022
30 Sep 2022	0%	0%	$185,000	28,440	0		$6.50	Q3 2022
30 Jun 2022	0%	0%	$148,000	28,440	0		$5.20	Q2 2022
31 Mar 2022	0%	0%	$196,000	28,440	0		$6.89	Q1 2022
31 Dec 2021	0%	0%	$354,000	28,440	0		$12.45	Q4 2021
30 Sep 2021	0%	0%	$889,000	28,440	0		$31.26	Q3 2021
30 Jun 2021	0%	0%	$911,000	28,440	0		$32.03	Q2 2021
31 Mar 2021	0%	+0%	$1,232,000	28,440	+5,931	+26%	$43.32	Q1 2021
31 Dec 2020	0%	0%	$1,611,000	22,509	0		$71.57	Q4 2020
30 Sep 2020	0%	+0%	$678,000	22,509	+22,509	NEW	$30.12	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.